Evidence map›Paper›PMID 26681260›Full record

ReviewCellular and molecular life sciences : CMLS2016

The myofibroblast, a key cell in normal and pathological tissue repair.

Ian A Darby, Noraina Zakuan, Fabrice Billet, Alexis Desmoulière

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 175 papers.

0numbers the graph read from it
0cells of the map it votes in
175citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

175 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. AirborneAdvanced healthcare materials · 2026
    Article
  8. Article
  9. Review
  10. The Secretome From Mechanically Loaded Myoblasts Enhances Tenocyte-Mediated Wound Healing in a 3D In Vitro Tendon Model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Collagen in Fibrotic Diseases.Sub-cellular biochemistry · 2026
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

115 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ian A DarbySchool of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083, Australia. ian.darby@rmit.edu.au.
Noraina ZakuanSchool of Medical Sciences, RMIT University, Bundoora, Melbourne, VIC, 3083, Australia.
Fabrice BilletDepartment of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex, France.
Alexis DesmoulièreDepartment of Physiology, Faculty of Pharmacy, University of Limoges, 2 rue du Dr. Marcland, 87025, Limoges Cedex, France. alexis.desmouliere@unilim.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myofibroblasts are characterized by their expression of α-smooth muscle actin, their enhanced contractility when compared to normal fibroblasts and their increased synthetic activity of extracellular matrix proteins. Myofibroblasts play an important role in normal tissue repair processes, particularly in the skin where they were first described. During normal tissue repair, they appear transiently and are then lost via apoptosis. However, the chronic presence and continued activity of myofibroblasts characterize many fibrotic pathologies, in the skin and internal organs including the liver, kidney and lung. More recently, it has become clear that myofibroblasts also play a role in many types of cancer as stromal or cancer-associated myofibroblast. The fact that myofibroblasts are now known to be key players in many pathologies makes understanding their functions, origin and the regulation of their differentiation important to enable them to be regulated in normal physiology and targeted in fibrosis, scarring and cancer.

Indexed as

AnimalsCicatrixHumansMyofibroblastsNeoplasmsWound HealingCancer stromaContractilityExcessive scarringExtracellular matrixFibrosisInnervationα-Smooth muscle actin

Identifiers

PMID26681260
PMCPMC11108523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.